News

In just a few months, hospitals and health systems nationwide will start working to vaccinate as many staff as possible against the flu, and more US hospitals than ever will require employees to get vaccinated.

New research illustrates that the risk of secondary cancers following CAR T-cell therapy is low.

Researchers develop fully human antibodies that can neutralize the alpha-latrotoxin of the European black widow, potentially reducing the need for antibodies derived from horses to treat disease caused by spider bites.

T-cell stimulating biomaterial that slowly biodegrades under the skin stimulates CAR-T cells in the body to improve therapeutic efficacy in an aggressive mouse tumor model.

The gene-editing approach uses prime editors and evolved enzymes called recombinases, and could pave the way to effective one-size-fits-all gene therapies for diseases such as cystic fibrosis.

Researchers have uncovered important immune signatures in children with infected flares of eczema. Technology Networks spoke to Dr. Rachel McLoughlin to learn how these findings could guide the development of a tailored eczema vaccine.

A new study adds evidence supporting the safety of COVID-19 vaccination during pregnancy, finding that vaccination is not associated with an increased risk of preterm birth.

Researchers at the Li Lab have developed oral insulin drops that when placed under the tongue are quickly and efficiently absorbed by the body, potentially replacing the need for insulin injections.

A new clinical trial in Shanghai, China, in partnership with Mass Eye and Ear researchers, demonstrated the restoration of hearing in both ears in five children born with autosomal deafness caused by mutations in the OTOF gene.

A key advisory panel to the US FDA has voted that midomafetamine (MDMA) is not effective nor risk-free for treating PTSD.